DOCETAXEL
Generic: DOCETAXEL
DOCETAXEL is FDA application NDA201525, sponsored by SANDOZ. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility a
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vi